Products & Services · Gross Profit
Adcirca — Gross Profit
United Therapeutics Adcirca — Gross Profit decreased by 56.8% to $1.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 44.1%, from $3.40M to $1.90M. Over 4 years (FY 2021 to FY 2025), Adcirca — Gross Profit shows a downward trend with a -14.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2019
Last reportedQ1 2026
Rolls up toGross Profit
How to read this metric
Higher gross profit indicates strong product margins and efficient manufacturing processes.
Detailed definition
Calculated as the difference between total product revenue and the direct cost of sales for that specific product. It me...
Peer comparison
Standard gross margin analysis used to evaluate the core profitability of individual pharmaceutical assets.
Metric ID:
uthr_segment_adcirca_gross_profitHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $13.30M | $8.50M | $4.60M | $5.80M | $5.70M | $6.30M | $5.70M | $4.20M | $4.40M | $3.90M | $4.10M | $3.80M | $3.10M | $3.90M | $2.90M | $3.40M | $3.80M | $5.30M | $4.40M | $1.90M |
| QoQ Change | — | -36.1% | -45.9% | +26.1% | -1.7% | +10.5% | -9.5% | -26.3% | +4.8% | -11.4% | +5.1% | -7.3% | -18.4% | +25.8% | -25.6% | +17.2% | +11.8% | +39.5% | -17.0% | -56.8% |
| YoY Change | — | — | — | — | -57.1% | -25.9% | +23.9% | -27.6% | -22.8% | -38.1% | -28.1% | -9.5% | -29.5% | +0.0% | -29.3% | -10.5% | +22.6% | +35.9% | +51.7% | -44.1% |
Range$1.90M – $13.30M
CAGR-33.6%
Avg YoY Growth-11.8%
Median YoY Growth-24.3%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is United Therapeutics's adcirca — gross profit?
- United Therapeutics (UTHR) reported adcirca — gross profit of $1.90M in Q1 2026.
- How has United Therapeutics's adcirca — gross profit changed year-over-year?
- United Therapeutics's adcirca — gross profit decreased by 44.1% year-over-year, from $3.40M to $1.90M.
- What is the long-term trend for United Therapeutics's adcirca — gross profit?
- Over 4 years (2021 to 2025), United Therapeutics's adcirca — gross profit has grown at a -14.8% compound annual growth rate (CAGR), from $32.00M to $16.90M.
- What does adcirca — gross profit mean?
- The profit remaining from product sales after subtracting direct production costs.